Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 20, 2020 - Issue 4
Submit an article Journal homepage
54
Views
0
CrossRef citations to date
0
Altmetric
Editorial

What is the potential of statins in the treatment of depression?

Nieves De Uribe ViloriaPsychiatry Department, Hospital Clínico Universitario, Valladolid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5988-1613View further author information
ORCID Icon &
Michael BerkSchool of Medicine, Barwon Health, IMPACT – the Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Australia;Orygen, the National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, AustraliaView further author information
Pages 307-309 | Published online: 19 Mar 2020

References

  • Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–744.
  • Pasco JA, Nicholson GC, Williams LJ, et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010;197(5):372–377.
  • Dahl J, Ormstad H, Aas HCD, et al. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand. 2016;134(1):40–47.
  • Cattaneo A, Gennarelli M, Uher R, et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline «predictors» and longitudinal «targets». Neuropsychopharmacology. 2013;38(3):377–385.
  • Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
  • Machado MO, Oriolo G, Bortolato B, et al. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review. J Affect Disord. 2017;209:235–245.
  • Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741.
  • Holahan CJ, Pahl SA, Cronkite RC, et al. Depression and vulnerability to incident physical illness across 10 years. J Affect Disord. 2010;123(1–3):222–229.
  • Köler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014;71(12):1381–1391.
  • Kim SW, Kang HJ, Jhon M, et al. Statins and inflammation: new therapeutic opportunities in psychiatry. Front Psychiatry. 2019;10:103.
  • Ridjker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009;373(9670):1175–1182.
  • Redlich C, Berk M, Williams LJ, et al. Statin use and risk of depression: a Swedish national cohort study. BMC Psychiatry. 2014;14(1):348.
  • Stafford L, Berk M. The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry. 2011;72(9):1229–1235.
  • Williams ED, Eastwood SV, Tillin T, et al. Statin use is associated with reduced depressive symptoms in Europeans, but increased symptoms in ethnic minorities in the UK: an observational study. Br J Clin Pharmacol. 2015;80(1):172–173.
  • Kessing LV, Rytgaar HC, Gerds TA, et al. New drug candidates for depression – a nationwide population-based study. Acta Psychiatr Scand. 2019;139(1):68–77.
  • Parsaik AK, Signh B, Murad MH, et al. Statins use and risk of depression: a systematic review and meta-analysis. J Affect Disord. 2014;160:62–67.
  • O’Neil A, Sanna L, Redlich C, et al. The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med. 10(1): 154. 2012.
  • Salagre E, Fernandez BS, Dodd S, et al. Statins for the treatment of depression: a meta-analysis of randomized double-blind, placebo-controlled trials. J Affect Disord. 2016;200:235–242.
  • Yatham MS, Yatham KS, Ravindran AV, et al. Do statins have an effect on depressive symptoms? A systematic review and meta-analysis. J Affect Disord. 2019;257:55–63.
  • Pennix BWJH. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74:277–286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.